In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...

The British Business Bank (BB) has agreed to make a £100 million investment in a new healthcare fund launched by London-based ...

The finding suggests the government has met its target of getting UK clinical trials up and running within an average of 150 ...

With one approved drug (Johnson & Johnson’s Spavaro) already doing $468 million per quarter in sales, and with companies like ...

Saqib Islam, chief executive Officer of newly launched Beeline Medicines. The pace of private financing in biopharma steps up ...

The report from the influential Cochrane Collaboration, an independent group that independently analyses clinical data, ...

The ABPI, in the 3 rd March blog by Pinchas Kahtan, highlighted “early signs of a modest recovery in clinical trial ...

That's the conclusion of a just-published report (PDF) from the influential Institute for Clinical and Economic Review (ICER) ...

Eli Lilly says it has the safety data it needs to shore up the recent speedy approval of its oral obesity therapy Foundayo, ...

Despite billions spent on new technology and improving data analytics, companies continue to struggle with commercial launch ...

Berkeley Heights, NJ – April 15, 2026: Axtria Inc., a global leader in AI-first data analytics solutions for the life ...

Japanese pharma group Daiichi Sankyo has reached a deal to sell its consumer healthcare division to food and beverage giant ...